老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

再鼎医药

36.42
+1.032.91%
盘前：35.00-1.4200-3.90%04:01 EDT
成交量：131.23万
成交额：4,814.44万
市值：39.18亿
市盈率：-14.02
高：37.99
开：35.99
低：35.25
收：35.39
数据加载中...
总览公司分析新闻公告
2020/01/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/23

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/07/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/26

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/06/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多